seed
Stage
1
Investors
About
BIOPHTA is a preclinical biotech company developing a game-changing technology for the treatment of eye diseases, specifically targeting glaucoma and macular edema, the two leading causes of blindness worldwide.
Explore BIOPHTA's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.